Detalhe da pesquisa
1.
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.
Mol Med
; 19: 367-76, 2013 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166682
2.
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.
Am J Pathol
; 176(3): 1462-8, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20093479
3.
Interleukin-8 is essential for normal urothelial cell survival.
Am J Physiol Renal Physiol
; 297(3): F816-21, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19535567
4.
A surgical orthotopic approach for studying the invasive progression of human bladder cancer.
Nat Protoc
; 14(3): 738-755, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683938
5.
Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
Bladder Cancer
; 4(1): 77-90, 2018 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29430509
6.
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Eur Urol
; 74(6): 741-753, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033047
7.
Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Front Biosci
; 11: 2007-16, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16720286
8.
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
PLoS One
; 11(3): e0150138, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26930657
9.
ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.
Cancer Res
; 75(23): 5155-66, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471361
10.
The urothelial glycosaminoglycan layer revisited.
J Urol
; 182(5): 2103-4, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19758629
11.
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines.
Cancer Lett
; 180(2): 131-7, 2002 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12175543
12.
Current preclinical models for the advancement of translational bladder cancer research.
Mol Cancer Ther
; 12(2): 121-30, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269072
13.
Research priorities in urothelial cell physiology: a report on the IUPS satellite meeting.
Physiologist
; 49(1): 106-11, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16572557
14.
Loss of 15-hydroxyprostaglandin dehydrogenase expression disrupts urothelial differentiation.
Urology
; 71(2): 346-50, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18308117
15.
Urology residency and research: round table discussion and plea for innovation.
Urology
; 71(5): 762-5; discussion 765-6, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18295864
16.
Erectile function outcome reporting after clinically localized prostate cancer treatment.
J Urol
; 178(2): 597-601, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17570435
17.
Proceedings of the Baltimore smooth muscle meeting: identifying research frontiers and priorities for the lower urinary tract.
J Urol
; 173(4): 1406-9, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15758814
18.
Effect of retinoic acid and interferon alpha-2a on transitional cell carcinoma of bladder.
J Urol
; 173(1): 247-51, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15592090
19.
Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstruction.
J Pharmacol Exp Ther
; 309(1): 398-403, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-14718596
20.
Growth inhibition and apoptosis induction by retinoic acid and interferon combined use on transitional cell carcinoma of bladder / 中华泌尿外科杂志
Chinese Journal of Urology
; (12)2001.
Artigo
em Zh
| WPRIM | ID: wpr-539701